$LSB
LakeShore Biopharma Co., Ltd. Stock $lsb

$lsb Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 20-F Financial Statement

#000121390023060012 Filed on July 26, 2023

Income Statement

Concept	2023 Q1	2023	2022 Q1
Revenue	$687.2M	$100.0M	$0.00
YoY Change		-80.12%
Cost Of Revenue	$153.4M	$22.32M
YoY Change		-80.94%
Gross Profit	$533.8M	$77.69M
YoY Change		-79.87%
Gross Profit Margin	77.68%	77.68%
Selling, General & Admin	$354.5M	$51.59M	$233.7K
YoY Change	151599.88%	-82.43%
% of Gross Profit	66.41%	66.41%
Research & Development	$318.7M	$46.38M
YoY Change		-78.04%
% of Gross Profit	59.7%	59.7%
Depreciation & Amortization	$19.50M	$4.327M	$16.30M
YoY Change	19.63%	-82.32%
% of Gross Profit	3.65%	5.57%
Operating Expenses	$673.2M	$97.97M	-$21.55K
YoY Change	-3124105.38%	-80.59%
Operating Profit	-$139.4M	-$20.28M
YoY Change		-82.95%
Interest Expense	-$30.86M	-$30.86M	$7.233M
YoY Change	-526.63%	1035.55%
% of Operating Profit
Other Income/Expense, Net	$25.89M	-$722.3K	-$127.6K
YoY Change	-20388.66%	-104.04%
Pretax Income	-$144.3M	-$21.01M	$7.127M
YoY Change	-2125.38%	-79.22%
Income Tax	$1.134M	$165.0K
% Of Pretax Income
Net Earnings	-$283.5M	-$21.17M	$7.127M
YoY Change	-4077.51%	-80.03%
Net Earnings / Revenue	-41.25%	-21.17%
Basic Earnings Per Share		-$0.23
Diluted Earnings Per Share	-$3.05	-$1.56	$0.28
COMMON SHARES
Basic Shares Outstanding	93.06M shares	93.06M shares
Diluted Shares Outstanding		93.06M shares

Balance Sheet

Concept	2023 Q1	2023	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$374.4M	$374.4M	$720.2K
YoY Change	51890.76%	36.72%
Cash & Equivalents	$53.90M		271.1M cnies
Short-Term Investments	$4.340M	$4.340M
Other Short-Term Assets	$131.2K	$8.063M	$63.43K
YoY Change	106.79%	-30.77%
Inventory	$26.98M	$185.4M	166.5M cnies
Prepaid Expenses
Receivables	$67.39M	$463.1M	308.6M cnies
Other Receivables	$5.035M	$5.035M
Total Short-Term Assets	$150.8M	$1.036B	$783.7K
YoY Change	19138.2%	35.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.20M	$582.9M	550.2M cnies
YoY Change	-84.88%	3.17%
Goodwill
YoY Change
Intangibles	$11.36M		80.72M cnies
YoY Change	-85.93%
Long-Term Investments			$200.0M
YoY Change
Other Assets	$3.045M	$22.83M	28.23M cnies
YoY Change	-89.21%	-26.99%	11564.1%
Total Long-Term Assets	$99.51M	$683.8M	$200.0M
YoY Change	-50.25%	1.0%
TOTAL ASSETS
Total Short-Term Assets	$150.8M	$1.036B	$783.7K
Total Long-Term Assets	$99.51M	$683.8M	$200.0M
Total Assets	$250.3M	$1.720B	$200.8M
YoY Change	24.63%	19.28%	82876.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.71M	$80.44M	30.81M cnies
YoY Change	-62.01%	161.07%
Accrued Expenses	$266.2M	$266.2M	$133.1K
YoY Change	199862.02%	16.88%	-26.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$193.7M	$193.7M
YoY Change		73.39%
Total Short-Term Liabilities	$95.87M	$658.8M	$133.1K
YoY Change	71920.09%	38.42%	-39.67%
LONG-TERM LIABILITIES
Long-Term Debt	$42.75M	$293.8M	$0.00
YoY Change		15.7%
Other Long-Term Liabilities	$38.75M	$38.75M	$12.87M
YoY Change	201.09%	-4.7%
Total Long-Term Liabilities	$48.39M	$332.5M	$12.87M
YoY Change	276.04%	12.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$95.87M	$658.8M	$133.1K
Total Long-Term Liabilities	$48.39M	$332.5M	$12.87M
Total Liabilities	$144.3M	$991.3M	$13.00M
YoY Change	1009.5%	28.66%	5792.89%
SHAREHOLDERS EQUITY
Retained Earnings	-1.874B cnies		-1.591B cnies
YoY Change	17.82%
Common Stock	$1.790K		7.978K cnies
YoY Change	-77.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	728.5M cnies	$728.5M	$187.8M
YoY Change
Total Liabilities & Shareholders Equity	$250.3M	$1.720B	$200.8M
YoY Change	24.63%	19.28%	82876.35%

Cashflow Statement

Concept	2023 Q1	2023	2022 Q1
OPERATING ACTIVITIES
Net Income	-$283.5M	-$21.17M	$7.127M
YoY Change	-4077.51%	-80.03%
Depreciation, Depletion And Amortization	$19.50M	$4.327M	$16.30M
YoY Change	19.63%	-82.32%
Cash From Operating Activities	-$75.10M	-$26.55M	-$165.0K
YoY Change	45420.67%	-84.7%
INVESTING ACTIVITIES
Capital Expenditures	$38.00M	$7.678M	$95.50M
YoY Change	-60.21%	-97.4%
Acquisitions
YoY Change
Other Investing Activities	$100.0K	$68.00K	$0.00
YoY Change		750.0%
Cash From Investing Activities	-$38.00M	-$8.292M	-$95.50M
YoY Change	-60.21%	-97.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	265.5M	$46.20M	320.7M
YoY Change	-17.21%	-87.33%
NET CHANGE
Cash From Operating Activities	-75.10M	-$26.55M	-165.0K
Cash From Investing Activities	-38.00M	-$8.292M	-95.50M
Cash From Financing Activities	265.5M	$46.20M	320.7M
Net Change In Cash	152.4M	$14.45M	-165.0K
YoY Change	-92474.83%	-112.1%
FREE CASH FLOW
Cash From Operating Activities	-$75.10M	-$26.55M	-$165.0K
Capital Expenditures	$38.00M	$7.678M	$95.50M
Free Cash Flow	-$113.1M	-$34.23M	-$95.66M
YoY Change	18.23%	-92.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41598
CY2023	dei	Entity Registrant Name EntityRegistrantName	YS Biopharma Co., Ltd.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Building No. 2
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	38 Yongda Road
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Daxing Biomedical Industry ParkDaxing District, Beijing, PRC
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	102629
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	93058197	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	2388
CY2023	dei	Auditor Name AuditorName	Wei, Wei & Co., LLP
CY2023	dei	Auditor Location AuditorLocation	Flushing, New York
CY2022Q1	us-gaap	Cash Cash	271067503	cny
CY2023Q1	us-gaap	Cash Cash	370108059	cny
CY2023Q1	us-gaap	Cash Cash	53859752	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	261766	cny
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	38093	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	308555105	cny
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	463051792	cny
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	67385333	usd
CY2022Q1	ys	Advance To Suppliers Current AdvanceToSuppliersCurrent	10648306	cny
CY2023Q1	ys	Advance To Suppliers Current AdvanceToSuppliersCurrent	6763326	cny
CY2023Q1	ys	Advance To Suppliers Current AdvanceToSuppliersCurrent	984229	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	166505565	cny
CY2023Q1	us-gaap	Inventory Net InventoryNet	185380952	cny
CY2023Q1	us-gaap	Inventory Net InventoryNet	26977451	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7987914	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10412769	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1515312	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	764764393	cny
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1035978664	cny
CY2023Q1	us-gaap	Assets Current AssetsCurrent	150760170	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	550153110	cny
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	571756443	cny
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83204512	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14850283	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11132428	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1620040	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3039084	cny
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1905581	cny
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	277309	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	80717978	cny
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78056792	cny
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11359168	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28228293	cny
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20923703	cny
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3044909	usd
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	676988748	cny
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	683774947	cny
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	99505938	usd
CY2022Q1	us-gaap	Assets Assets	1441753141	cny
CY2023Q1	us-gaap	Assets Assets	1719753611	cny
CY2023Q1	us-gaap	Assets Assets	250266108	usd
CY2022Q1	us-gaap	Debt Current DebtCurrent	111733754	cny
CY2023Q1	us-gaap	Debt Current DebtCurrent	193736563	cny
CY2023Q1	us-gaap	Debt Current DebtCurrent	28193397	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	30811100	cny
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	80439489	cny
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11705908	usd
CY2022Q1	ys	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	326751353	cny
CY2023Q1	ys	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	377536644	cny
CY2023Q1	ys	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	54940793	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4322252	cny
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4753547	cny
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	691757	usd
CY2022Q1	ys	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	2295701	cny
CY2023Q1	ys	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	2295701	cny
CY2023Q1	ys	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	334081	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	475914160	cny
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	658761944	cny
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	95865936	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	253928000	cny
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	293790596	cny
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	42753699	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10605260	cny
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6348890	cny
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	923918	usd
CY2022Q1	ys	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	30053517	cny
CY2023Q1	ys	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	23606507	cny
CY2023Q1	ys	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	3435323	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8792389	cny
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1279507	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	294586777	cny
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	332538382	cny
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	48392447	usd
CY2022Q1	us-gaap	Liabilities Liabilities	770500937	cny
CY2023Q1	us-gaap	Liabilities Liabilities	991300326	cny
CY2023Q1	us-gaap	Liabilities Liabilities	144258383	usd
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	458074468	cny
CY2022Q1	ys	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount1 RedeemableNoncontrollingInterestEquityPreferredCarryingAmount1	912146924	cny
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1370221392	cny
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00002
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00002
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00002
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9950000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9950000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9950000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61827883	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61827883	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93058197	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93058197	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93058197	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93058197	shares
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	808502018	cny
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2656891036	cny
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	386642466	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1590567163	cny
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1874037965	cny
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-272718245	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	83087979	cny
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54412083	cny
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7918286	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-698969188	cny
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	728453285	cny
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	106007725	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1441753141	cny
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1719753611	cny
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	250266108	usd
CY2021	us-gaap	Revenues Revenues	257015929	cny
CY2022	us-gaap	Revenues Revenues	502949894	cny
CY2023	us-gaap	Revenues Revenues	687201070	cny
CY2023	us-gaap	Revenues Revenues	100004521	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	59656877	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	117066090	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	153360262	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	22317660	usd
CY2021	us-gaap	Gross Profit GrossProfit	197359052	cny
CY2022	us-gaap	Gross Profit GrossProfit	385883804	cny
CY2023	us-gaap	Gross Profit GrossProfit	533840808	cny
CY2023	us-gaap	Gross Profit GrossProfit	77686861	usd
CY2021	us-gaap	Selling Expense SellingExpense	73485259	cny
CY2022	us-gaap	Selling Expense SellingExpense	185999704	cny
CY2023	us-gaap	Selling Expense SellingExpense	272927356	cny
CY2023	us-gaap	Selling Expense SellingExpense	39717589	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	155334386	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107620500	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81595277	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11874103	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	94387144	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	211222263	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	318700526	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46378702	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	323206789	cny
CY2022	us-gaap	Operating Expenses OperatingExpenses	504842467	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	673223159	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	97970394	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-125847737	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-118958663	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-139382351	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-20283533	usd
CY2021	ys	Late Fees Related To Income Tax LateFeesRelatedToIncomeTax	11464741	cny
CY2021	ys	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax	7261947	cny
CY2022	ys	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax	231231	cny
CY2023	ys	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax	3603	cny
CY2023	ys	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax	524	usd
CY2021	ys	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	7701793	cny
CY2022	ys	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	1852378	cny
CY2023	ys	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	747609	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	38864606	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-137500062	cny
CY2023	ys	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	108795	usd
CY2021	ys	Government Grants Income GovernmentGrantsIncome	3530405	cny
CY2022	ys	Government Grants Income GovernmentGrantsIncome	23020413	cny
CY2023	ys	Government Grants Income GovernmentGrantsIncome	26072517	cny
CY2023	ys	Government Grants Income GovernmentGrantsIncome	3794187	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-29689927	cny
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2717433	cny
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-30857673	cny
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4490544	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21358	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3108	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4063743	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-327987	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	551760	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	80295	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-48524260	cny
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17891384	cny
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4963250	cny
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-722273	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-174371997	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-101067279	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-144345601	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21005806	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17454245	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4937122	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1133504	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	164952	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-191826242	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21170758	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	16610297	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	130662326	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	137991697	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	20081159	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-208436539	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236666727	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-283470802	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41251917	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-191826242	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-106004401	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-145479105	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-21170758	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	22455217	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20009614	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-169371025	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-67139795	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-282979167	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41180372	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.1
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.71
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.56
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61827883	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61827883	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93058197	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93058197	shares
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-847320829	cny
CY2021	ys	Shareholders Contribution ShareholdersContribution	447682944	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	16610297	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-191826242	cny
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	76756500	cny
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	22455217	cny
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-508862707	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	130662326	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7764448	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	38795798	cny
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-698969188	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	137991697	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1636897084	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3505001	cny
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	216378193	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8870007	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	483066	cny
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-137500062	cny
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	728453285	cny
CY2023Q1	ys	Balance Balance	106007725	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-191826242	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21170758	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17454245	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4937120	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1133504	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	164952	usd
CY2021	us-gaap	Depreciation Depreciation	22240060	cny
CY2022	us-gaap	Depreciation Depreciation	24475736	cny
CY2023	us-gaap	Depreciation Depreciation	29735024	cny
CY2023	us-gaap	Depreciation Depreciation	4327171	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5665735	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6678233	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6952783	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1011800	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-24876	cny
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-273982	cny
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	76756500	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7764448	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3505001	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	510063	usd
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-6414634	cny
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-5084925	cny
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-10750948	cny
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-1564525	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1109400	cny
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	4393630	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-723583	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-105299	usd
CY2021	ys	Non Cash Lease Expense NonCashLeaseExpense	2233089	cny
CY2022	ys	Non Cash Lease Expense NonCashLeaseExpense	3787628	cny
CY2023	ys	Non Cash Lease Expense NonCashLeaseExpense	4423612	cny
CY2023	ys	Non Cash Lease Expense NonCashLeaseExpense	643743	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21358	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3108	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	68728378	cny
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	89459313	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18151804	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2641530	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	220734141	cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	99137291	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	165247635	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24047562	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	3086330	cny
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-30088833	cny
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-146767686	cny
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-59229801	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8992574	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1308639	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4424337	cny
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	14427864	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	49628389	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	7222141	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-245808	cny
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	140210	cny
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-35633487	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	43029496	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6261841	usd
CY2021	ys	Increase Decrease In Deferred Government Grants IncreaseDecreaseInDeferredGovernmentGrants	-44290	cny
CY2022	ys	Increase Decrease In Deferred Government Grants IncreaseDecreaseInDeferredGovernmentGrants	-656673	cny
CY2023	ys	Increase Decrease In Deferred Government Grants IncreaseDecreaseInDeferredGovernmentGrants	-6447010	cny
CY2023	ys	Increase Decrease In Deferred Government Grants IncreaseDecreaseInDeferredGovernmentGrants	-938197	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-34105055	cny
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2222291	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3796392	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4550232	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-662170	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-246610437	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-173545357	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-182469396	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26553749	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	644842	cny
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000	cny
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	68001	cny
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9896	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104883783	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	295314351	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52758124	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7677594	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3617607	cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4291597	cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	624532	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104238941	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-298923958	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56981720	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8292230	usd
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	729412999	cny
CY2021	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1589236	cny
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	252457329	cny
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	36738701	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	35884661	cny
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5222094	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	32253609	cny
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	414116587	cny
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	247387392	cny
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	36000901	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	160407571	cny
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	49558442	cny
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	146510134	cny
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	21320799	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	299757219	cny
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	163346796	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	739258696	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	364558145	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	317449926	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	46196709	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2674	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-11478411	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21303512	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3100180	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	388406644	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-119389581	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	99302322	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14450910	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2050440	cny
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	390457084	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	271067503	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39446935	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	390457084	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	271067503	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	370369825	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53897845	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	34105055	cny
CY2021	us-gaap	Interest Paid Net InterestPaidNet	8124572	cny
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2404357	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	27289057	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3971224	usd
CY2021	ys	Accretion To Redemption Value Of Convertible Redeemable Preferred Shares AccretionToRedemptionValueOfConvertibleRedeemablePreferredShares	16610297	cny
CY2022	ys	Accretion To Redemption Value Of Convertible Redeemable Preferred Shares AccretionToRedemptionValueOfConvertibleRedeemablePreferredShares	130662326	cny
CY2023	ys	Accretion To Redemption Value Of Convertible Redeemable Preferred Shares AccretionToRedemptionValueOfConvertibleRedeemablePreferredShares	137991697	cny
CY2023	ys	Accretion To Redemption Value Of Convertible Redeemable Preferred Shares AccretionToRedemptionValueOfConvertibleRedeemablePreferredShares	20081159	usd
CY2021	ys	Operating Right Of Use Assets Recognized For Related Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedForRelatedOperatingLeaseLiabilities	15048446	cny
CY2022	ys	Operating Right Of Use Assets Recognized For Related Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedForRelatedOperatingLeaseLiabilities	1516478	cny
CY2023	ys	Operating Right Of Use Assets Recognized For Related Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedForRelatedOperatingLeaseLiabilities	331218	cny
CY2023	ys	Operating Right Of Use Assets Recognized For Related Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedForRelatedOperatingLeaseLiabilities	48200	usd
CY2021	ys	Forgiveness Of Amounts Due To Related Parties ForgivenessOfAmountsDueToRelatedParties	446092527	cny
CY2023	ys	Equity Transaction From Warrants EquityTransactionFromWarrants	-8870007	cny
CY2023	ys	Equity Transaction From Warrants EquityTransactionFromWarrants	-1290802	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	1636897084	cny
CY2023	us-gaap	Stock Issued1 StockIssued1	238208461	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of the CFS in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions reflected in these CFFS include, but are not limited to, the valuation of YS Group’s convertible redeemable preferred shares and ordinary shares, accrual of stock-based compensation expense, allowance for doubtful accounts and obsolete inventories, useful life of property, plant and equipment, income taxes and uncertain tax positions. Actual amounts could differ from those estimates. Changes in estimates are recorded in the period when they become known. Due to the risks and uncertainties involved in YS Group’s business and evolving market conditions and, given the subjective element of the estimates and assumptions made, actual results may differ from estimated results.</p>
CY2023	ys	Number Of Companies And Their Subsidiaries Owned NumberOfCompaniesAndTheirSubsidiariesOwned	4	pure
CY2023Q1	us-gaap	Shares Issued SharesIssued	1	shares
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	191826242	cny
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	106004401	cny
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	145479105	cny
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1590567163	cny
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1874037965	cny
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	370400000	cny
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53900000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	487500000	cny
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	70900000	usd
CY2023Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax	1	usd
CY2023Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax	6.8717	cny
CY2023	us-gaap	Payments To Suppliers PaymentsToSuppliers	54870	cny
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b><i>Concentrations of Credit Risk and Significant Suppliers</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Financial instruments that potentially subject YS Group to concentration of credit risk consist of cash. YS Group mitigates this risk by maintaining its cash with high quality, accredited financial institutions. As of March 31, 2023, YS Group’s cash was deposited at more than two financial institutions and it did not have any foreign currency exchange contracts, option contracts or other hedging arrangements. YS Group has not experienced any losses on its deposits of cash and does not believe that it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">YS Group’s sales are made primarily to Centers for Disease Control and Prevention (“CDCs”) located in China. YS Group does not have a concentration of its revenue and accounts receivable with specific customers. As of March 31, 2023 and 2022, there was no customers which accounted for more than 10% of YS Group’s accounts receivable balance. During the years ended March 31, 2023, 2022 and 2021, there were no customers that accounted for more than 10% of YS Group’s net revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Details of percentage of YS Group’s top 5 vendors accounting for total purchases are as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> Year Ended March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">48,006,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,986,117</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">37.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,178,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,208,772</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vendor G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,053,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,463,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor H</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,846,214</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">996,291</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,746,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">690,736</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">84,830,864</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,344,960</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">66.9</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> Year Ended March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">35,172,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,540,508</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,227,146</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,556,181</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9.6</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vendor C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,995,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,574,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,426,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,169,859</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor E</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,621,300</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,043,020</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,442,385</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,884,060</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">44.7</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> Year Ended March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">32,063,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,879,324</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">37.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,781,888</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">879,870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.8</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vendor G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,862,320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">739,933</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.7</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,568,088</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">695,157</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor H</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,199,200</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">486,844</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">50,474,996</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,681,128</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">59.6</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Details of percentage of YS Group’s top 5 vendors accounting for accounts payable are as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3,220,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">468,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">4.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor H</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,118</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,346</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,236,538</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">470,996</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.0</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Vendor E</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,420,549</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">223,772</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">4.6</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,420,549</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">223,772</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.6</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">%</td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">YS Group’s business operation has been, and may continue to be, negatively affected by the outbreak of COVID-19. While many of the restrictions on movements within China have been relaxed, there is great uncertainty around the future of the COVID - 19 outbreak and how it will impact YS Group’s operations, particularly in terms of the spread of Omicron virus in China.</p>
CY2022	ys	Account Receivable Balance Percentage AccountReceivableBalancePercentage	0.10	pure
CY2023	ys	Account Receivable Balance Percentage AccountReceivableBalancePercentage	0.10	pure
CY2022	ys	Net Revenue Percentage NetRevenuePercentage	0.10	pure
CY2023	ys	Net Revenue Percentage NetRevenuePercentage	0.10	pure
CY2023	ys	Percentage Of Late Fees Related To Social Security Insurance PercentageOfLateFeesRelatedToSocialSecurityInsurance	0.0005	pure
CY2023Q1	ys	Late Fees For Its Liabilities Related To Social Security Insurance LateFeesForItsLiabilitiesRelatedToSocialSecurityInsurance	9900000	cny
CY2022Q1	ys	Late Fees For Its Liabilities Related To Social Security Insurance LateFeesForItsLiabilitiesRelatedToSocialSecurityInsurance	9500000	cny
CY2021Q1	ys	Late Fees For Its Liabilities Related To Social Security Insurance LateFeesForItsLiabilitiesRelatedToSocialSecurityInsurance	29400000	cny
CY2022Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2807847	cny
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	500000	cny
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	57926980	cny
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	50453180	cny
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	7342169	usd
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	40795744	cny
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	322170980	cny
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	487418616	cny
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	70931300	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13615875	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24366824	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3545967	usd
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	308555105	cny
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	463051792	cny
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	67385333	usd
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8530951	cny
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13615875	cny
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1981442	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5084924	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10750949	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1564525	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13615875	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	24366824	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3545967	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	61275177	cny
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	8917033	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73285870	cny
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	78432041	cny
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11413775	usd
CY2022Q1	us-gaap	Inventory Adjustments InventoryAdjustments	5503029	cny
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	4779446	cny
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	695526	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	166505565	cny
CY2023Q1	us-gaap	Inventory Net InventoryNet	185380952	cny
CY2023Q1	us-gaap	Inventory Net InventoryNet	26977451	usd
CY2021Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	41301797	cny
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	5503029	cny
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	800825	usd
CY2022	ys	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	4393629	cny
CY2023	ys	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	3670046	cny
CY2023	ys	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	534081	usd
CY2022	ys	Inventories Written Off InventoriesWrittenOff	40192397	cny
CY2023	ys	Inventories Written Off InventoriesWrittenOff	4393629	cny
CY2023	ys	Inventories Written Off InventoriesWrittenOff	639380	usd
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	5503029	cny
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	4779446	cny
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	695526	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	730447603	cny
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	780512580	cny
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	113583622	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	150402597	cny
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	178864241	cny
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26029112	usd
CY2022Q1	ys	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	29891896	cny
CY2023Q1	ys	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	29891896	cny
CY2023Q1	ys	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	4349998	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	550153110	cny
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	571756443	cny
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83204512	usd
CY2014	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	29900000	cny
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4339791	cny
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	631545	usd
CY2022Q1	ys	Staff Advances Current StaffAdvancesCurrent	383251	cny
CY2023Q1	ys	Staff Advances Current StaffAdvancesCurrent	606859	cny
CY2023Q1	ys	Staff Advances Current StaffAdvancesCurrent	88313	usd
CY2022Q1	ys	Staffs Social Security Current StaffsSocialSecurityCurrent	615581	cny
CY2023Q1	ys	Staffs Social Security Current StaffsSocialSecurityCurrent	252090	cny
CY2023Q1	ys	Staffs Social Security Current StaffsSocialSecurityCurrent	36685	usd
CY2022Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	3442733	cny
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	4249718	cny
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	618438	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	178699	cny
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	26005	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	854245	cny
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	901355	cny
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	131169	usd
CY2022Q1	ys	Allowance On Prepaid Expenses And Other Current Assets AllowanceOnPrepaidExpensesAndOtherCurrentAssets	115743	cny
CY2023Q1	ys	Allowance On Prepaid Expenses And Other Current Assets AllowanceOnPrepaidExpensesAndOtherCurrentAssets	115743	cny
CY2023Q1	ys	Allowance On Prepaid Expenses And Other Current Assets AllowanceOnPrepaidExpensesAndOtherCurrentAssets	16843	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7987914	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10412769	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1515312	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	152933740	cny
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	157225338	cny
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22880123	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	72215762	cny
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	79168546	cny
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11520955	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	80717978	cny
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	78056792	cny
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11359168	usd
CY2022Q1	us-gaap	Debt Current DebtCurrent	111733754	cny
CY2023Q1	us-gaap	Debt Current DebtCurrent	193736563	cny
CY2023Q1	us-gaap	Debt Current DebtCurrent	28193397	usd
CY2022Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	253928000	cny
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	293790596	cny
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	42753699	usd
CY2022Q1	srt	Bank Loans BankLoans	365661754	cny
CY2023Q1	srt	Bank Loans BankLoans	487527159	cny
CY2023Q1	srt	Bank Loans BankLoans	70947096	usd
CY2023Q2	ys	Repaid Amount RepaidAmount	31700000	cny
CY2023Q2	ys	Repaid Amount RepaidAmount	20900000	cny
CY2023Q3	ys	Repaid Amount RepaidAmount	32400000	cny
CY2023	ys	Repayment Instalment RepaymentInstalment	40000000	usd
CY2023	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	23400000	cny
CY2023	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	3400000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	40000000	cny
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	23600000	cny
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.05	pure
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5000000	cny
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0325	pure
CY2023Q2	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	4700000	usd
CY2023Q2	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	4700000	cny
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2900000	cny
	ys	Repaid Amount RepaidAmount	2900000	cny
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	32000000	cny
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	2800000	cny
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	5800000	cny
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14850283	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11132428	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1620040	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4322252	cny
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4753547	cny
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	691757	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10605260	cny
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6348890	cny
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	923918	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2643917	cny
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	4594967	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	5002684	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	728013	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2601625	cny
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4587894	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3349856	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	487486	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5178993	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	753670	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5040835	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	733564	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1526270	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	222110	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11746098	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1709344	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	643661	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	93669	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	11102437	cny
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1615675	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	57459273	cny
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	55188497	cny
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	8031273	usd
CY2022Q1	ys	Accrued Promotional Service Fee Current AccruedPromotionalServiceFeeCurrent	64883477	cny
CY2023Q1	ys	Accrued Promotional Service Fee Current AccruedPromotionalServiceFeeCurrent	87567459	cny
CY2023Q1	ys	Accrued Promotional Service Fee Current AccruedPromotionalServiceFeeCurrent	12743202	usd
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1171381	cny
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	379595	cny
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	55240	usd
CY2022Q1	ys	Accrued Late Fees Current AccruedLateFeesCurrent	9499595	cny
CY2023Q1	ys	Accrued Late Fees Current AccruedLateFeesCurrent	9927056	cny
CY2023Q1	ys	Accrued Late Fees Current AccruedLateFeesCurrent	1444629	usd
CY2022Q1	ys	Payable For Property Plant And Equipment Current PayableForPropertyPlantAndEquipmentCurrent	48774134	cny
CY2023Q1	ys	Payable For Property Plant And Equipment Current PayableForPropertyPlantAndEquipmentCurrent	47579463	cny
CY2023Q1	ys	Payable For Property Plant And Equipment Current PayableForPropertyPlantAndEquipmentCurrent	6923973	usd
CY2022Q1	ys	Cdc Transportation And Storage Fee Current CdcTransportationAndStorageFeeCurrent	35023095	cny
CY2023Q1	ys	Cdc Transportation And Storage Fee Current CdcTransportationAndStorageFeeCurrent	49976200	cny
CY2023Q1	ys	Cdc Transportation And Storage Fee Current CdcTransportationAndStorageFeeCurrent	7272756	usd
CY2022Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	94528659	cny
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	108795884	cny
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	15832455	usd
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7758448	cny
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5121970	cny
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	745372	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6055245	cny
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	881186	usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7653291	cny
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6945275	cny
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1010707	usd
CY2022	ys	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	326751353	cny
CY2023	ys	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	377536644	cny
CY2023	ys	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	54940793	usd
CY2023	ys	Payments Of Salaries Social Security Insurance PaymentsOfSalariesSocialSecurityInsurance	2300000	cny
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	49020045	cny
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47390831	cny
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6896522	usd
CY2022Q1	ys	Accrued Social Security Insurance Current AccruedSocialSecurityInsuranceCurrent	7732161	cny
CY2023Q1	ys	Accrued Social Security Insurance Current AccruedSocialSecurityInsuranceCurrent	7179828	cny
CY2023Q1	ys	Accrued Social Security Insurance Current AccruedSocialSecurityInsuranceCurrent	1044840	usd
CY2022Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	707067	cny
CY2023Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	617838	cny
CY2023Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	89911	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	57459273	cny
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	55188497	cny
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8031273	usd
CY2023Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.00002
CY2020Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings	440585213	cny
CY2020Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings	69403171	usd
CY2021	ys	Temporary Equity Stock Issued During Period Value Conversion TemporaryEquityStockIssuedDuringPeriodValueConversion	131425527	cny
CY2021	ys	Temporary Equity Stock Issued During Period Value Conversion TemporaryEquityStockIssuedDuringPeriodValueConversion	20702802	usd
CY2021	ys	Temporary Equity Shares Subscribed For Call Option Value TemporaryEquitySharesSubscribedForCallOptionValue	131425290	cny
CY2021	ys	Temporary Equity Shares Subscribed For Call Option Value TemporaryEquitySharesSubscribedForCallOptionValue	20702765	usd
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	597987709	cny
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	94197995	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	16610297	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2616536	usd
CY2021	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-32575465	cny
CY2021	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-5131449	usd
CY2021Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings	1285458571	cny
CY2021Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings	202491820	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	130662326	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	20582579	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-45899505	cny
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-7230318	usd
CY2022Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings	1370221392	cny
CY2022Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings	215844081	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	137991697	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	20081159	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	118457680	cny
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	795044	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1626670769	cny
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	236720284	usd
CY2023Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.00002
CY2023	ys	Fair Value Of The Underlying Asset As Of The Valuation Date FairValueOfTheUnderlyingAssetAsOfTheValuationDate	1.6
CY2023Q1	us-gaap	Derivative Price Risk Option Strike Price DerivativePriceRiskOptionStrikePrice	11.5
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.629	pure
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	100	shares
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.1
CY2023Q1	ys	Aggregate Value AggregateValue	8700000	cny
CY2023	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	21358	cny
CY2023	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	8814592	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21358	cny
CY2023	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	-845	cny
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8792389	cny
CY2023Q1	ys	Warrant Liabilities Ending Balance WarrantLiabilitiesEndingBalance	1279507	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	10000000	shares
CY2023Q1	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	750000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023	ys	Ordinary Shares OrdinaryShares	10	usd
CY2023	us-gaap	Class Of Warrant Or Right Expense Or Revenue Recognized ClassOfWarrantOrRightExpenseOrRevenueRecognized	(1) may be less than the value the holders would have received if they had exercised their Warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the warrants, including because the number of YS Biopharma Ordinary Shares received is capped at 0.361 YS Biopharma Ordinary Shares per warrant (subject to adjustment) irrespective of the remaining life of the warrants
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P30D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.3156
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.3156
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.402
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3253565	shares
CY2015Q1	ys	Term In Each Calendar Year Into Which Plan Is Divided TermInEachCalendarYearIntoWhichPlanIsDivided	P6M
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	76756500	cny
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7764448	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3505001	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	510063	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	143750	shares
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.2056	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.1826	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.36	pure
CY2021	ys	Effective Income Tax Rate Reconciliation Effect Of Prc Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPrcPreferentialTaxRate	-0.0077	pure
CY2022	ys	Effective Income Tax Rate Reconciliation Effect Of Prc Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPrcPreferentialTaxRate	0.0456	pure
CY2023	ys	Effective Income Tax Rate Reconciliation Effect Of Prc Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPrcPreferentialTaxRate	0.0872	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.078	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.332	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.255	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.1001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.0488	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.0079	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1149	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4447	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2323	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0999	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0491	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0078	pure
CY2022Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	825454	cny
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	716917	cny
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	104329	usd
CY2022Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2031460	cny
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1769405	cny
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	257492	usd
CY2022Q1	ys	Deferred Tax Assets Deferred Government Grants DeferredTaxAssetsDeferredGovernmentGrants	4852383	cny
CY2023Q1	ys	Deferred Tax Assets Deferred Government Grants DeferredTaxAssetsDeferredGovernmentGrants	3296223	cny
CY2023Q1	ys	Deferred Tax Assets Deferred Government Grants DeferredTaxAssetsDeferredGovernmentGrants	479681	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	58257270	cny
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39366020	cny
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5728716	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58257270	cny
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39366020	cny
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5728716	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7709297	cny
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5782545	cny
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	841502	usd
CY2022Q1	ys	Deferred Tax Liabilities Fair Value Adjustments Arising From Historical Acquisition Of Subsidiaries DeferredTaxLiabilitiesFairValueAdjustmentsArisingFromHistoricalAcquisitionOfSubsidiaries	4670213	cny
CY2023Q1	ys	Deferred Tax Liabilities Fair Value Adjustments Arising From Historical Acquisition Of Subsidiaries DeferredTaxLiabilitiesFairValueAdjustmentsArisingFromHistoricalAcquisitionOfSubsidiaries	3876964	cny
CY2023Q1	ys	Deferred Tax Liabilities Fair Value Adjustments Arising From Historical Acquisition Of Subsidiaries DeferredTaxLiabilitiesFairValueAdjustmentsArisingFromHistoricalAcquisitionOfSubsidiaries	564193	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4670213	cny
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3876964	cny
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	564193	usd
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3039084	cny
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1905581	cny
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	277309	usd
CY2023	ys	Government Assistance Addition Received That Were Deferred GovernmentAssistanceAdditionReceivedThatWereDeferred	4000000	cny
CY2022	ys	Government Assistance Addition Received That Were Deferred GovernmentAssistanceAdditionReceivedThatWereDeferred	3600000	cny
CY2022Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	32349218	cny
CY2023Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	25902208	cny
CY2023Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	3769404	usd
CY2022Q1	ys	Current Portion CurrentPortion	2295701	cny
CY2023Q1	ys	Current Portion CurrentPortion	2295701	cny
CY2023Q1	ys	Current Portion CurrentPortion	334081	usd
CY2022Q1	ys	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	30053517	cny
CY2023Q1	ys	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	23606507	cny
CY2023Q1	ys	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	3435323	usd
CY2023Q1	ys	Purchase Commitment Other Professional Service Fee PurchaseCommitmentOtherProfessionalServiceFee	3229699	cny
CY2023Q1	ys	Purchase Commitment Other Professional Service Fee PurchaseCommitmentOtherProfessionalServiceFee	470000	usd
CY2023Q1	ys	Purchase Commitment Research And Development PurchaseCommitmentResearchAndDevelopment	185648604	cny
CY2023Q1	ys	Purchase Commitment Research And Development PurchaseCommitmentResearchAndDevelopment	27016401	usd
CY2023Q1	ys	Purchase Commitment Raw Materials PurchaseCommitmentRawMaterials	15528566	cny
CY2023Q1	ys	Purchase Commitment Raw Materials PurchaseCommitmentRawMaterials	2259785	usd
CY2023Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	204406869	cny
CY2023Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	29746186	usd
CY2023	ys	Related To Payable RelatedToPayable	278707	cny
CY2023	ys	Subsidiaries Exceed Percentage SubsidiariesExceedPercentage	0.25	pure
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent		cny
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		cny
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount		cny
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount		usd
CY2023Q1	ys	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount1 RedeemableNoncontrollingInterestEquityPreferredCarryingAmount1		cny
CY2023Q1	ys	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount1 RedeemableNoncontrollingInterestEquityPreferredCarryingAmount1		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		cny
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2022	ys	Late Fees Related To Income Tax LateFeesRelatedToIncomeTax		cny
CY2023	ys	Late Fees Related To Income Tax LateFeesRelatedToIncomeTax		cny
CY2023	ys	Late Fees Related To Income Tax LateFeesRelatedToIncomeTax		usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		cny
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.56
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.71
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.10
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61827883	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61827883	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93058197	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93058197	shares
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		cny
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		cny
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		cny
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2022	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock		cny
CY2023	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock		cny
CY2023	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock		usd
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		cny
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		cny
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		cny
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		cny
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		cny
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	ys	Forgiveness Of Amounts Due To Related Parties ForgivenessOfAmountsDueToRelatedParties		cny
CY2023	ys	Forgiveness Of Amounts Due To Related Parties ForgivenessOfAmountsDueToRelatedParties		cny
CY2023	ys	Forgiveness Of Amounts Due To Related Parties ForgivenessOfAmountsDueToRelatedParties		usd
CY2021	ys	Equity Transaction From Warrants EquityTransactionFromWarrants		cny
CY2022	ys	Equity Transaction From Warrants EquityTransactionFromWarrants		cny
CY2021	us-gaap	Stock Issued1 StockIssued1		cny
CY2022	us-gaap	Stock Issued1 StockIssued1		cny
CY2021	us-gaap	Payments To Suppliers PaymentsToSuppliers		usd
CY2022	us-gaap	Payments To Suppliers PaymentsToSuppliers		usd
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance		cny
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent		cny
CY2021	ys	Temporary Equity Stock Transferred From To Another Series Value TemporaryEquityStockTransferredFromToAnotherSeriesValue		cny
CY2021	ys	Temporary Equity Stock Transferred From To Another Series Value TemporaryEquityStockTransferredFromToAnotherSeriesValue		usd
CY2023Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings		cny
CY2023Q1	ys	Temporary Equity Shares Outstandings TemporaryEquitySharesOutstandings		usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		cny
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		cny
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		cny
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001946399

Files In Submission

Name	View Source	Status
0001213900-23-060012-index-headers.html	Edgar Link	pending
0001213900-23-060012-index.html	Edgar Link	pending
0001213900-23-060012.txt	Edgar Link	pending
0001213900-23-060012-xbrl.zip	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
f20f2023ex12-1_ysbiopharmaco.htm	Edgar Link	pending
f20f2023ex12-2_ysbiopharmaco.htm	Edgar Link	pending
f20f2023ex13-1_ysbiopharmaco.htm	Edgar Link	pending
f20f2023ex13-2_ysbiopharmaco.htm	Edgar Link	pending
f20f2023ex15-1_ysbiopharmaco.htm	Edgar Link	pending
f20f2023ex2-1_ysbiopharmaco.htm	Edgar Link	pending
f20f2023ex8-1_ysbiopharmaco.htm	Edgar Link	pending
f20f2023_ysbiopharmaco.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
image_024.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
image_026.jpg	Edgar Link	pending
image_027.jpg	Edgar Link	pending
image_028.jpg	Edgar Link	pending
image_029.jpg	Edgar Link	pending
image_030.jpg	Edgar Link	pending
image_031.jpg	Edgar Link	pending
image_032.jpg	Edgar Link	pending
image_033.jpg	Edgar Link	pending
image_034.jpg	Edgar Link	pending
image_035.jpg	Edgar Link	pending
image_036.jpg	Edgar Link	pending
f20f2023_ysbiopharmaco_htm.xml	Edgar Link	completed
image_037.jpg	Edgar Link	pending
image_038.jpg	Edgar Link	pending
image_039.jpg	Edgar Link	pending
image_040.jpg	Edgar Link	pending
image_041.jpg	Edgar Link	pending
image_042.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ys-20230331.xsd	Edgar Link	pending
ys-20230331_def.xml	Edgar Link	unprocessable
ys-20230331_lab.xml	Edgar Link	unprocessable
ys-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ys-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSB
LakeShore Biopharma Co., Ltd. Stock $lsb

2023 Q1 Form 20-F Financial Statement

#000121390023060012 Filed on July 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSB LakeShore Biopharma Co., Ltd. Stock $lsb

2023 Q1 Form 20-F Financial Statement

#000121390023060012 Filed on July 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSB
LakeShore Biopharma Co., Ltd. Stock $lsb